๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Myasthenia Gravis

TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study NCT04182984n/a1 site๐Ÿ“ Xi'an Tang-Du Hospital ยท Tests: Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil) A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE) NCT07647510Phase 34 sites๐Ÿ“ Pasadena๐Ÿ“ Boca Raton๐Ÿ“ Fayetteville Dianthus Therapeutics ยท Tests: Claseprubart, Placebo, Claseprubart, Placebo A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG) NCT06987539Phase 214 sites๐Ÿ“ Chicago๐Ÿ“ Philadelphia๐Ÿ“ Austin Amgen ยท Tests: Inebilizumab Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases NCT07470151NA1 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: EVM18001 Injection Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs) NCT04202341n/a51 sites๐Ÿ“ Birmingham๐Ÿ“ Scottsdale๐Ÿ“ Fresno Alexion Pharmaceuticals, Inc. The EXPLORE MG Registry for Myasthenia Gravis NCT03792659n/a1 site๐Ÿ“ New Haven Yale University ยท Tests: Blood Sample Draw Universal Chimeric Antigen Receptor T-Cell ๏ผˆUCAR T-cell๏ผ‰ Therapy Targeting CD19/B Cell Maturation Antigen ๏ผˆCD19/BCMA๏ผ‰ in Patients With r/r Neurological Autoimmune Diseases NCT06939166EARLY Phase 11 site๐Ÿ“ Tianjin Tianjin Huanhu Hospital ยท Tests: UCAR T-cell Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology NCT07136844NA1 site๐Ÿ“ Liรจge Centre Hospitalier Universitaire de Liege ยท Tests: Syde, Dynamometric measurements of muscle strength, The 6-minute walk test (6MWT), The 10-meter test (10MWT), The 4 staโ€ฆ GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103) NCT07058298EARLY Phase 11 site๐Ÿ“ Wuhan Daishi Tian ยท Tests: GC012F injection A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa NCT06298565n/a35 sites๐Ÿ“ San Francisco๐Ÿ“ Boca Raton๐Ÿ“ Jacksonville Beach argenx ยท Tests: efgartigimod Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA) NCT06940323n/a1 site๐Ÿ“ San Francisco University of California, San Francisco MuSK Myasthenia 1000 Study NCT06259071n/a1 site๐Ÿ“ Washington D.C. George Washington University Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis NCT04833894Phase 2, Phase 325 sites๐Ÿ“ Chicago๐Ÿ“ Chapel Hill๐Ÿ“ Charlottesville argenx ยท Tests: Efgartigimod IV Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG) NCT07596784Phase 310 sites๐Ÿ“ Beijing๐Ÿ“ Changchun๐Ÿ“ Fuzhou Alexion Pharmaceuticals, Inc. ยท Tests: Ravulizumab Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis NCT05067348Phase 26 sites๐Ÿ“ Beijing๐Ÿ“ Changsha๐Ÿ“ Xi'an Tang-Du Hospital ยท Tests: Tocilizumab Injectable Product Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?" NCT06866652n/a1 site๐Ÿ“ Paris Institut de Myologie, France Capturing Key MG-symptoms Using Smartphone Recordings. NCT06743490n/a2 sites๐Ÿ“ Leiden๐Ÿ“ Leiden Leiden University Medical Center Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis NCT06491238NA1 site๐Ÿ“ Saint Paul HealthPartners Institute ยท Tests: Light Intensity Exercise, Moderate Intensity Exercise Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases NCT07085676Phase 11 site๐Ÿ“ Jerusalem Polina Stepensky ยท Tests: HBI0101 CART Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG) NCT07413835NA1 site๐Ÿ“ Xuzhou The Affiliated Hospital of Xuzhou Medical University ยท Tests: HN2302 Injection Cohort Study on Neuroimmune Diseases in the Reproductive Age NCT07653984n/a1 site๐Ÿ“ Guangzhou Third Affiliated Hospital, Sun Yat-Sen University Myasthenia Gravis Registry in China NCT06241521n/a16 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Huashan Hospital ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis NCT07673627Phase 28 sites๐Ÿ“ Carlsbad๐Ÿ“ Miami๐Ÿ“ Las Vegas argenx ยท Tests: Empasiprubart IV, Placebo IV, Efgartigimod PH20 SC PFS Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites๐Ÿ“ Sioux Falls๐Ÿ“ Sydney Sanford Health Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis NCT07246564Phase 412 sites๐Ÿ“ Beijing๐Ÿ“ Changchun๐Ÿ“ Changsha UCB Biopharma SRL ยท Tests: Rozanolixizumab Unhideยฎ Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site๐Ÿ“ Delafield Brain Inflammation Collaborative Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial. NCT06342544Phase 311 sites๐Ÿ“ Bordeaux๐Ÿ“ Garches๐Ÿ“ Lille Fondation Ophtalmologique Adolphe de Rothschild ยท Tests: immediate treatment with corticosteroids, addition of rituximab if recurrence Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis NCT07411963n/a8 sites๐Ÿ“ Nice๐Ÿ“ Bron๐Ÿ“ Garches Centre Hospitalier Universitaire de Nice ยท Tests: early use of Ravulizumab A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis NCT06055959Phase 2, Phase 39 sites๐Ÿ“ Chicago๐Ÿ“ Denton๐Ÿ“ Milan UCB Biopharma SRL ยท Tests: Zilucoplan A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy NCT06249438Phase 11 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: CD20/BCMA-directed CAR-T cells
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy